Striatech Leads Ethical Vision Research at FELASA 2025
Striatech, a pioneer in non-invasive vision research technologies, will showcase its latest advancements at the FELASA 2025 Congress in Athens,
Read moreStriatech, a pioneer in non-invasive vision research technologies, will showcase its latest advancements at the FELASA 2025 Congress in Athens,
Read moreThe unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
Read moreAt Striatech, advancing the future of ophthalmic research is a central commitment. In partnership with the ARVO Foundation for Eye
Read moreA groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read moreDarkAdapt, an advanced extension of the OptoDrum system, enables precise and reproducible studies with dark-adapted rodents. This innovative instrument provides
Read moreGroundbreaking research from Harvard Medical School indicates that vision loss caused by optic nerve damage, glaucoma, and aging may not
Read moreThe Ksander Lab at Boston’s Schepens Eye Research Institute has unveiled valuable insights into the role of subretinal microglia in
Read moreMillions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read moreAbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
Read moreIn a groundbreaking leap, researchers have engineered microscopic magnetic robots that could transform the treatment of deadly brain bleeds caused
Read more